Skip to main content
SpringerLink
Log in

Prevention of ischemic stroke

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

The primary risk factors for stroke are known, and attention to primary care of these disorders should reduce the incidence of stroke significantly. Control of hypertension, diabetes, and hyperlipidemia have all been shown to reduce the rate of stroke. Identification of potential cardioembolic sources of stroke, particularly atrial fibrillation, can prevent stroke with appropriate application of anticoagulation. Duplex Doppler B-mode sonography can establish the extent of carotid artery disease in patients with cervical bruit or risk factors for atherosclerosis, and indicate which conditions should be managed medically or surgically. Patients with a history suggestive of transient ischemic attacks can also be screened noninvasively with duplex sonography to determine if they have a critical carotid stenosis and require carotid endarterectomy. New advances in platelet antiaggregant therapy with ticlopidine, clopidogrel, and the combination of aspirin with dipyridamole have also reduced the rate of stroke to a greater degree than standard treatment with aspirin. The incidence of this devastating illness could possibly be reduced by 50% with attentive primary care management. The cardiologist is often involved in the treatment of patients at risk for stroke, and is in an ideal position to provide this care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sherman DG, Dyken MJ, Gent M, et al.: Antithrombotic therapy for cerebrovascular disorders. An update. Chest 1995, 106:444S-456S.

    Google Scholar 

  2. Kannel WB, Dawber TR, Sorlie P, Wolf PA: Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham Study. Stroke 1976, 7:327–331.

    PubMed  CAS  Google Scholar 

  3. Klungel OH, Kaplan RC, Heckbert SR, et al.: Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 2000, 31:420–424.

    PubMed  CAS  Google Scholar 

  4. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA 1970, 213:1142–1152.

    Google Scholar 

  5. Hypertension-Stroke Cooperative Study Group: Effect of antihypertensive treatment on stroke recurrence. JAMA 1974, 229:409–418.

    Article  Google Scholar 

  6. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255–3264.

    Article  Google Scholar 

  7. Frishman WH, Dhruva N: Systemic hypertension in the elderly: recognition and approaches to therapy. Cardiol Elderly 1994, 2:355.

    Google Scholar 

  8. Gueyffier F, Boutitie F, Boissei JP, et al.: Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997, 126:761–767.

    PubMed  CAS  Google Scholar 

  9. Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998, 351:1755–1762. An analysis of blood pressure control and aspirin in the prevention of stroke in hypertensive patients.

    Article  PubMed  CAS  Google Scholar 

  10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group [no authors listed]. JAMA 1991, 265:3255–3264. Documentation that control of isolated systolic hypertension in the elderly prevents stroke.

  11. Fagard RH, Staessen JA: Treatment of isolated systolic hypertension in the elderly: Systolic Hypertension in Europe (Syst-Eur) Trial. Investigators Clin Exp Hypertens 1999, 21:491–497.

    Article  CAS  Google Scholar 

  12. Voko Z, Bots ML, Hofman A, et al.: J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 1999, 34:1181–1185.

    PubMed  CAS  Google Scholar 

  13. Kristensen B, Malm J, Carlberg B, et al.: Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke 1997, 28:1702–1709.

    PubMed  CAS  Google Scholar 

  14. Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979, 241:2035–2038.

    Article  PubMed  CAS  Google Scholar 

  15. Merimee TJ: Diabetic retinopathy: a synthesis of perspectives. New Engl J Med 1990, 322:978–983.

    Article  PubMed  CAS  Google Scholar 

  16. Woo J, Lam CWK, Kay R, et al.: The influence of hyperglycemia and diabetes mellitus on immediate and 3 month morbidity and mortality after acute stroke. Arch Neurol 1990, 47:1174–1177.

    PubMed  CAS  Google Scholar 

  17. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Lancet 2000, 355:253–259. Prevention of cardiovascular events and stroke in diabetic patients with the ACE inhibitor ramipril.

    Article  Google Scholar 

  18. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145–153. Prevention of cardiovascular events and stroke in high-risk cardiac patients with the ACE inhibitor ramipril.

    Article  Google Scholar 

  19. Gordon T, Castelli WP, Hjortland MD, et al.: Highdensity lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977, 62:707–714.

    Article  PubMed  CAS  Google Scholar 

  20. Prospective Studies Collaboration: Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995, 346:1647–1653.

    Article  Google Scholar 

  21. Iso H, Jacobs DR, Wentworth D, et al.: Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial (MRFIT). N Engl J Med 1989, 320:904–910.

    Article  PubMed  CAS  Google Scholar 

  22. Yano K, Reed DM, MacLean CJ: Serum cholesterol and hemorrhagic stroke in the Honolulu heart program. Stroke 1989, 20:1460–1465.

    PubMed  CAS  Google Scholar 

  23. Konishi M, Iso H, Komachi Y, et al.: Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke 1993, 24:954–964.

    PubMed  CAS  Google Scholar 

  24. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [no authors listed]. Lancet 1994, 344:1383–1389.

  25. Lewis SJ, Sacks FM, Mitchell JS, et al.: Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol 1998, 32:140–146.

    Article  PubMed  CAS  Google Scholar 

  26. PlehnJF, Davis BR, Sacks FM, et al.: Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. Circulation 1999, 99:216–223. Prevention of stroke in patients with MI using the platelet antiaggregant clopidogrel.

    PubMed  CAS  Google Scholar 

  27. Weinberger J: Medical treatment of patients with carotid artery disease. In Treatment of Carotid Disease: A Practitioner’s Manual. Edited by Bederson JB, Tuhrim S. Lebanon, NH: American Association of Neurological Surgeons; 1999.

    Google Scholar 

  28. Bucher HC, Griffith LE, Guyatt GH: Effect of HMG-CoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 1998, 128:89–95. A meta-analysis of the efficacy of cholesterol reduction in the prevention of stroke.

    PubMed  CAS  Google Scholar 

  29. White HD, Simes RJ, Anderson NE, et al.: Pravastatin therapy and the risk of stroke. N Engl J Med 2000, 343:317–326.

    Article  PubMed  CAS  Google Scholar 

  30. O’Brien ER, Schwartz SM: A new view of restenosis. In Syndromes of Atherosclerosis. Correlation of Clinical Imaging and Pathology. Edited by Fuster V. Armonk, NY: Futura; 1996.

    Google Scholar 

  31. Weinberger J, Terashita D: Drug therapy of neurovascular disease. Heart Dis 1999, 1:163–168.

    PubMed  CAS  Google Scholar 

  32. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998, 338:1042–1050.

    Article  PubMed  CAS  Google Scholar 

  33. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study: Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995, 273:14212–1428.

    Google Scholar 

  34. Weinberger J, Ramos R, Ambrose JA, Fuster V: Morphology and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. J Am Coll Cardiol 1988, 12:515–1521.

    Article  Google Scholar 

  35. Amarenco P, Cohen A, Tzourio C, et al.: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474–1479. Identification of atherosclerotic plaque in the aortic arch as a risk factor for stroke.

    Article  PubMed  CAS  Google Scholar 

  36. Weinberger J, Papamitsakis N, Newfield A, et al.: Plaque moprhology correlates with cerebrovascular symptoms in patients with complex aortic arch plaque. Arch Neurol 2000, 57:81–84.

    Article  PubMed  CAS  Google Scholar 

  37. Geraci A, Weinberger J: Natural history of aortic arch plaque. Neurology 2000, 54:749–751.

    PubMed  CAS  Google Scholar 

  38. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449–1457.

    Article  Google Scholar 

  39. Smith P, Arnesen H, Holme I: The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990, 323:147–152.

    Article  PubMed  CAS  Google Scholar 

  40. Polak JF, Bajakian RL, O’Leary DH, et al.: Detection of internal carotid artery stenosis: Comparison of MR angiography, color Doppler sonography and arteriography. Radiology 1992, 182:35–40.

    PubMed  CAS  Google Scholar 

  41. Can U, Furie KL, Suwanwela N, et al.: Transcranial Doppler ultrasound criteria for hemodynamically significant internal carotid artery stenosis based on residual lumen diameter calculated from en bloc endarterectomy specimens. Stroke 1997, 28:1966–1971.

    PubMed  CAS  Google Scholar 

  42. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325:445–453.

    Article  Google Scholar 

  43. Barnett HJM, for the NASCET Collaborators: Final results of the North American Symptomatic Carotid Endarterectomy Trial. Stroke 1998, 29:286. The definitive analysis of the role of carotid artery endarterectomy in the prevention of stroke in patients with TIA and carotid artery stenosis.

    Google Scholar 

  44. Dietrich EB, Ndiaye M, Reid DB: Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996, 3:42–62.

    Article  Google Scholar 

  45. Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978, 299:53–59.

    Article  Google Scholar 

  46. Antiplatelet Trialists’ Collaboration: Collaborative overview of randomized trials of anitplatelet therapy: 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy. BMJ 1994, 308:81–106.

    Google Scholar 

  47. Hass WK, Easton JD, Adams HP, et al., for the Ticlopidine Aspirin Stroke Study Group: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989, 321:501–507.

    Article  PubMed  CAS  Google Scholar 

  48. Caprie Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329–1339.

    Article  Google Scholar 

  49. Diener HC, Cunha L, Forbes C, et al.: European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1–13.

    Article  PubMed  CAS  Google Scholar 

  50. Chimowitz MI, Kokkinos J, Strong J, et al.: The warfarinaspirin symptomatic intracranial disease study. Neurology 1988, 45:1488–1493.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, The Mount Sinai School of Medicine, 1 Gustav Levy Place, Box 1052, 10029, New York, NY, USA

    Jesse Weinberger MD

Authors
  1. Jesse Weinberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weinberger, J. Prevention of ischemic stroke. Curr Treat Options Cardio Med 4, 393–403 (2002). https://doi.org/10.1007/s11936-002-0019-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-002-0019-z

Keywords

Search

Navigation